Peregrine Ventures is a venture capital firm primarily focused on global strategic investments in life science and healthcare companies, including pharmaceuticals, biotech, medical devices, and digital health, across all stages of development. Their strategy involves providing not only capital but also deep industry knowledge, strategic guidance, and operational support to help portfolio companies bring groundbreaking medical technologies to market.
40% of their portfolio is in Healthcare. Average disclosed round size is $59.1M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$600M
Top Stage
Unknown
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Lutris Pharma | Unknown | $30M | Jan 2025 |
 Cordio Medical | Series A | $18M | Jun 2022 |
 Aleph Farms | Series B | $105M | Jul 2021 |
 KAHR | Unknown | $46.5M | Jun 2021 |
 Memic | Series D | $96M | Apr 2021 |
Top Co-Investors
aMoon2 shared
Cancer Focus Fund1 shared
Pavilion Capital1 shared
Mirae Asset1 shared
Columbus Venture Partners1 shared
Pontifax1 shared
Accel1 shared
OurCrowd1 shared
Accelmed Partners1 shared
L Catterton1 shared
DisruptAD1 shared
CJ CheilJedang1 shared
Cargill1 shared
CPT Capital1 shared
Last updated: 16 April 2026